Latest Press Releases
View all
TimeHeadline
15m agoEpsium Enterprise Limited Files Annual Report on Form 20-F for Fiscal Year 2025
48m agoNewmark Names Jack Fuchs as President of Global Asset Services and Member of the Executive Committee
1h agoStop the Rail Merger Coalition Launches to Oppose Union Pacific-Norfolk Southern Merger
1h agoNorthEast Community Bancorp, Inc. Reports Results for the Three Months Ended March 31, 2026
1h agoBetter Home Equity Card Powered by Stripe Enables Easy Access to HELOC Funds and Introduces a Modern Access Layer Across the $21.4 Trillion Home Equity Market
Nuvectis Pharma Inc logo

Nuvectis Pharma Inc

About

Nuvectis Pharma Inc (NASDAQ:NVCT) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 31 2026
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting
Feb 11 2026
Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights
Dec 17 2025
Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC
Nov 25 2025
Nuvectis Pharma to Host a Virtual Key Opinion Leader Meeting to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, Including the Combination with Osimertinib in NSCLC
Nov 4 2025
CORRECTION: Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights

Financials

Revenue
$0
Market Cap
$200.28 M
EPS
-1.32

Community Chat

Ask AI

6ix6ix